370 related articles for article (PubMed ID: 32710500)
21. Risk of COVID-19 death in cancer patients: an analysis from Guy's Cancer Centre and King's College Hospital in London.
Russell B; Moss CL; Shah V; Ko TK; Palmer K; Sylva R; George G; Monroy-Iglesias MJ; Patten P; Ceesay MM; Benjamin R; Potter V; Pagliuca A; Papa S; Irshad S; Ross P; Spicer J; Kordasti S; Crawley D; Wylie H; Cahill F; Haire A; Zaki K; Sita-Lumsden A; Josephs D; Enting D; Swampillai A; Sawyer E; D'Souza A; Gomberg S; Harrison C; Fields P; Wrench D; Rigg A; Sullivan R; Kulasekararaj A; ; Dolly S; Van Hemelrijck M
Br J Cancer; 2021 Sep; 125(7):939-947. PubMed ID: 34400804
[TBL] [Abstract][Full Text] [Related]
22. When hematologic malignancies meet COVID-19 in the United States: Infections, death and disparities.
Wang Q; Berger NA; Xu R
Blood Rev; 2021 May; 47():100775. PubMed ID: 33187811
[TBL] [Abstract][Full Text] [Related]
23. Severe manifestations of SARS-CoV-2 in children and adolescents: from COVID-19 pneumonia to multisystem inflammatory syndrome: a multicentre study in pediatric intensive care units in Spain.
García-Salido A; de Carlos Vicente JC; Belda Hofheinz S; Balcells Ramírez J; Slöcker Barrio M; Leóz Gordillo I; Hernández Yuste A; Guitart Pardellans C; Cuervas-Mons Tejedor M; Huidobro Labarga B; Vázquez Martínez JL; Gutiérrez Jimeno M; Oulego-Erróz I; Trastoy Quintela J; Medina Monzón C; Medina Ramos L; Holanda Peña MS; Gil-Antón J; Sorribes Ortí C; Flores González JC; Hernández Palomo RM; Sánchez Ganfornina I; Fernández Romero E; García-Besteiro M; López-Herce Cid J; González Cortés R;
Crit Care; 2020 Nov; 24(1):666. PubMed ID: 33243303
[TBL] [Abstract][Full Text] [Related]
24. Changes in respiratory infection trends during the COVID-19 pandemic in patients with haematologic malignancy.
Ryoo J; Kim SC; Lee J
BMC Pulm Med; 2024 May; 24(1):259. PubMed ID: 38797852
[TBL] [Abstract][Full Text] [Related]
25. A nomogramic model based on clinical and laboratory parameters at admission for predicting the survival of COVID-19 patients.
Ma X; Wang H; Huang J; Geng Y; Jiang S; Zhou Q; Chen X; Hu H; Li W; Zhou C; Gao X; Peng N; Deng Y
BMC Infect Dis; 2020 Nov; 20(1):899. PubMed ID: 33256643
[TBL] [Abstract][Full Text] [Related]
26. Molnupiravir is effective in patients with haematological malignancies.
Bołkun Ł; Pula B; Kołkowska-Leśniak A; Morawska M; Cichocka E; Charlinski G; Garus B; Giebel S; Piszcz J; Drozd-Sokolowska J; Kwiatkowski J; Biernat M; Hus I; Lech-Maranda E; Długosz-Danecka M; Giannopoulos K; Wróbel T
Int J Cancer; 2023 Sep; 153(6):1251-1256. PubMed ID: 36691818
[TBL] [Abstract][Full Text] [Related]
27. Haematological malignancy and nosocomial transmission are associated with an increased risk of death from COVID-19: results of a multi-center UK cohort.
Bhogal T; Khan UT; Lee R; Stockdale A; Hesford C; Potti-Dhananjaya V; Jathanna A; Rahman S; Tivey A; Shotton R; Sundar R; Valerio C; Norouzi A; Walker P; Suckling R; Armstrong A; Brearton G; Pettitt A; Kalakonda N; Palmer DH; Jackson R; Turtle L; Palmieri C
Leuk Lymphoma; 2021 Jul; 62(7):1682-1691. PubMed ID: 33508995
[TBL] [Abstract][Full Text] [Related]
28. Long and persistent COVID-19 in patients with hematologic malignancies: from bench to bedside.
Laracy JC; Kamboj M; Vardhana SA
Curr Opin Infect Dis; 2022 Aug; 35(4):271-279. PubMed ID: 35849516
[TBL] [Abstract][Full Text] [Related]
29. Elevated cardiac troponin I as a predictor of outcomes in COVID-19 hospitalizations: a meta-analysis.
Malik P; Patel U; Patel NH; Somi S; Singh J
Infez Med; 2020 Dec; 28(4):500-506. PubMed ID: 33257623
[TBL] [Abstract][Full Text] [Related]
30. Australia and New Zealand consensus position statement: use of COVID-19 therapeutics in patients with haematological malignancies.
Campbell A; Teh B; Mulligan S; Ross DM; Weinkove R; Gilroy N; Gangatharan S; Prince HM; Szer J; Trotman J; Lane S; Dickinson M; Quach H; Enjeti AK; Ku M; Gregory G; Hapgood G; Ho PJ; Cochrane T; Cheah C; Greenwood M; Latimer M; Berkahn L; Wight J; Armytage T; Diamond P; Tam CS; Hamad N
Intern Med J; 2024 Feb; 54(2):328-336. PubMed ID: 38146232
[TBL] [Abstract][Full Text] [Related]
31. Prolonged shedding of viable SARS-CoV-2 in immunocompromised patients with haematological malignancies: A prospective study.
Ichikawa T; Tamura T; Takahata M; Ishio T; Ibata M; Kasahara I; Minauchi K; Yamamoto S; Teshima T; Fukuhara T
Br J Haematol; 2024 Mar; 204(3):815-820. PubMed ID: 37795527
[TBL] [Abstract][Full Text] [Related]
32. Mortality and clinical outcomes following SARS-CoV-2 infection among individuals with haematological malignancies: A Danish population-based cohort study.
Lund LC; Rahbek MT; Brown P; Obel N; Hallas J; Frederiksen H
Eur J Haematol; 2023 Dec; 111(6):946-950. PubMed ID: 37740535
[TBL] [Abstract][Full Text] [Related]
33. COVID-19 in children with haematological malignancies.
Millen GC; Arnold R; Cazier JB; Curley H; Feltbower R; Gamble A; Glaser A; Grundy RG; Kirton L; Lee LYW; McCabe MG; Palles C; Phillips B; Stiller CA; Varnai C; Kearns P
Arch Dis Child; 2022 Feb; 107(2):186-188. PubMed ID: 34301621
[TBL] [Abstract][Full Text] [Related]
34. Retrospective cohort study of admission timing and mortality following COVID-19 infection in England.
Alaa A; Qian Z; Rashbass J; Benger J; van der Schaar M
BMJ Open; 2020 Nov; 10(11):e042712. PubMed ID: 33234660
[TBL] [Abstract][Full Text] [Related]
35. COVID-19 in Patients with Hematologic Disorders Undergoing Therapy: Perspective of a Large Referral Hematology Center in Rome.
Girmenia C; Gentile G; Micozzi A; Petrucci L; Malaspina F; Di Prima A; Baldacci E; Bianchi S; Pugliese P; Turriziani O; Antonelli G; Tombolini V; Foà R; Martelli M
Acta Haematol; 2020; 143(6):574-582. PubMed ID: 32932252
[TBL] [Abstract][Full Text] [Related]
36. Clinical features associated with COVID-19 outcome in multiple myeloma: first results from the International Myeloma Society data set.
Chari A; Samur MK; Martinez-Lopez J; Cook G; Biran N; Yong K; Hungria V; Engelhardt M; Gay F; García Feria A; Oliva S; Oostvogels R; Gozzetti A; Rosenbaum C; Kumar S; Stadtmauer EA; Einsele H; Beksac M; Weisel K; Anderson KC; Mateos MV; Moreau P; San-Miguel J; Munshi NC; Avet-Loiseau H
Blood; 2020 Dec; 136(26):3033-3040. PubMed ID: 33367546
[TBL] [Abstract][Full Text] [Related]
37. Wage-subsidised employment as a result of permanently reduced work capacity in a nationwide cohort of patients diagnosed with haematological malignancies.
Horsboel TA; Nielsen CV; Nielsen B; Andersen NT; De Thurah A
Acta Oncol; 2015 May; 54(5):743-9. PubMed ID: 25752974
[TBL] [Abstract][Full Text] [Related]
38. Fatality rate and predictors of mortality in an Italian cohort of hospitalized COVID-19 patients.
Bellan M; Patti G; Hayden E; Azzolina D; Pirisi M; Acquaviva A; Aimaretti G; Aluffi Valletti P; Angilletta R; Arioli R; Avanzi GC; Avino G; Balbo PE; Baldon G; Baorda F; Barbero E; Baricich A; Barini M; Barone-Adesi F; Battistini S; Beltrame M; Bertoli M; Bertolin S; Bertolotti M; Betti M; Bobbio F; Boffano P; Boglione L; Borrè S; Brucoli M; Calzaducca E; Cammarata E; Cantaluppi V; Cantello R; Capponi A; Carriero A; Casciaro FG; Castello LM; Ceruti F; Chichino G; Chirico E; Cisari C; Cittone MG; Colombo C; Comi C; Croce E; Daffara T; Danna P; Della Corte F; De Vecchi S; Dianzani U; Di Benedetto D; Esposto E; Faggiano F; Falaschi Z; Ferrante D; Ferrero A; Gagliardi I; Gaidano G; Galbiati A; Gallo S; Garavelli PL; Gardino CA; Garzaro M; Gastaldello ML; Gavelli F; Gennari A; Giacomini GM; Giacone I; Giai Via V; Giolitti F; Gironi LC; Gramaglia C; Grisafi L; Inserra I; Invernizzi M; Krengli M; Labella E; Landi IC; Landi R; Leone I; Lio V; Lorenzini L; Maconi A; Malerba M; Manfredi GF; Martelli M; Marzari L; Marzullo P; Mennuni M; Montabone C; Morosini U; Mussa M; Nerici I; Nuzzo A; Olivieri C; Padelli SA; Panella M; Parisini A; Paschè A; Pau A; Pedrinelli AR; Percivale I; Re R; Rigamonti C; Rizzi E; Rognoni A; Roveta A; Salamina L; Santagostino M; Saraceno M; Savoia P; Sciarra M; Schimmenti A; Scotti L; Spinoni E; Smirne C; Tarantino V; Tillio PA; Vaschetto R; Vassia V; Zagaria D; Zavattaro E; Zeppegno P; Zottarelli F; Sainaghi PP
Sci Rep; 2020 Nov; 10(1):20731. PubMed ID: 33244144
[TBL] [Abstract][Full Text] [Related]
39. COVID-19 in haematology patients: a multicentre West Midlands clinical outcomes analysis on behalf of the West Midlands Research Consortium.
Morrissey H; Ball P; Mandal A; Nevil A; Paneesha S; Basu S; Karim F; Hossain MI; Phillips N; Khawaja J; Stone J; Murray D; Randall K; Murthy V; Kishore B; Nikolousis M; Pratt G; Neilson J; Pemberton N; Wandroo F
Br J Haematol; 2021 Jan; 192(1):e11-e14. PubMed ID: 33151540
[No Abstract] [Full Text] [Related]
40. Current outcomes of SARS-CoV-2 Omicron variant infection in high-risk haematological patients treated early with antivirals.
Aiello TF; Puerta-Alcalde P; Chumbita M; Lopera C; Monzó P; Cortes A; Fernández-Avilés F; Suárez-Lledó M; Correa J; Ortiz-Maldonado V; Cuesta G; Martinez-Cibrian N; Esteve J; Marcos MÁ; Mensa J; Soriano A; Garcia-Vidal C
J Antimicrob Chemother; 2023 Jun; 78(6):1454-1459. PubMed ID: 37051877
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
